X0206 3 2023-06-05 0 0001850079 Telesis Bio Inc. TBIO 0001979440 Novalis LifeSciences Investments II GP, LLC 1 LIBERTY LANE E, SUITE 112 HAMPTON NH 03842 0 0 1 0 0001890017 Novalis LifeSciences Investments II, L.P. 1 LIBERTY LANE E, SUITE 112 HAMPTON NH 03842 0 0 1 0 0001033876 MEISTER PAUL M 1 LIBERTY LANE E, SUITE 112 HAMPTON NH 03842 1 0 1 0 0001216068 DEKKERS MARIJN E 1 LIBERTY LANE E, SUITE 112 HAMPTON NH 03842 0 0 1 0 Redeemable Convertible Preferred Stock 2.3633 Common Stock 6558625 I See footnotes Warrant (right to buy) 2.5996 2023-06-05 2030-06-05 Common Stock 6558626 I See footnotes Warrant (right to buy) 2.5996 2023-06-05 2025-06-05 Common Stock 3279313 I See footnotes Each share of Redeemable Convertible Preferred Stock has a stated value of $100 (the "Stated Value") and accrues dividends daily at an initial rate of 8.0% per annum. The Stated Value, as adjusted to give effect to such dividends, is referred to as the "Accrued Value." Each share of Redeemable Convertible Preferred Stock is convertible, at the option of the holder or, upon the occurrence of certain events, at the option of the Issuer, into a number of shares of the Issuer's Common Stock determined by dividing the Accrued Value by the conversion price. The Redeemable Convertible Preferred Stock is not convertible to the extent that such conversion would result in the holder of such Redeemable Convertible Preferred Stock, together with its attribution parties, beneficially owning in excess of 19.99% of the Issuer's voting power. The warrants are not exercisable to the extent that such exercise would result in the holder of such warrant, together with its attribution parties, beneficially owning in excess of 19.99% of the Issuer's voting power. Represents securities held directly by Novalis LifeSciences Investments II, L.P. ("Novalis LifeSciences"). Novalis LifeSciences Investments II GP, LLC ("Novalis LifeSciences GP"), whose managers are Marijn Dekkers and Paul Meister, is the general partner of Novalis LifeSciences. As a result, Novalis LifeSciences GP, Mr. Dekkers and Mr. Meister may each be deemed to share voting and dispositive power with respect to the securities held by Novalis LifeSciences. Novalis LifeSciences GP, Mr. Dekkers and Mr. Meister each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Mr. Meister is a director of the issuer. Novalis LifeSciences Investments II GP, LLC, By: /s/ Paul M. Meister, Title: Authorized Signatory 2023-06-08 Novalis LifeSciences Investments II, L.P., By: Novalis LifeSciences Investments II GP, LLC, its general partner, By: /s/ Paul M. Meister, Title: Authorized Signatory 2023-06-08 /s/ Paul M. Meister 2023-06-08 /s/ Marijn E. Dekkers 2023-06-08